ReleaseWire Connect

"Rex Trueform Clothing Company Limited - Company Capsule" contains a company overview, key facts, key employees, products and services, competitor benchmarking data, locations and subsidiaries as well as financial ratios.

Canadean's "Autobacs Seven Co. Ltd. - Company Capsule" contains a company overview, key facts, mergers & acquisitions, key employees, products and services, competitor benchmarking data, locations and subsidiaries as well as financial ratios.

Canadean's "Shoe Carnival, Inc. - Company Capsule" is a crucial resource for industry executives and anyone looking to access key information about "Shoe Carnival, Inc."

Canadean's "Amer Sports Corporation - Company Capsule" contains a company overview, key facts, mergers & acquisitions, key employees, products and services, locations and subsidiaries as well as financial ratios.

“Remote Patient Monitoring Devices Market to 2017 - Chronic Disease Prevalence and Government Curbs on Hospital Spending to Drive the Market” provides key data, information and analysis on the global remote patient monitoring (RPM) market. The report provides information on the market landscape, competitive landscape and market trends for two RPM market categories: external RPM devices and implantable RPM devices.

“Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge” examines the key issues influencing the global OTC market and assesses why companies switch Rx drugs to OTC, their business strategies and the potential challenges and opportunities this creates. It provides an analysis of the global OTC market and forecasts broken down by geography and therapy areas. It discusses the national and international factors which impact the OTC market and companies operating in the OTC market. The report reviews the regulatory landscape in the US, Europe and Japan and highlights recent changes in regulatory procedures and guidelines. Therapy profiles provide a detailed analysis of the leading OTC drug classes and Company profiles provide a detailed analysis of the leading OTC companies. Finally the report discusses the challenges and future opportunities in the OTC market, business strategies and future outlook.

“Electronic Medical Records Market to 2017 - Government Financial Incentives and Benefits in terms of Costs and Quality of Healthcare Drive Adoption among Physicians and Hospitals” provides key data, information and analysis on the global Electronic Medical Records (EMR) market.

“Growth Strategies for Supergenerics Organizations - Opportunities in Addressing Unmet Medical Needs and Providing Cost-Effective Solutions for Product Development in Emerging Markets” which assesses the strategies that companies have used to improve the efficacy, safety, ease of use and manufacture of products. It discusses the key advantages and market drivers to develop and differentiate supergenerics. It analyzes the regulatory and legislative implications on the development of supergenerics, and gives an introduction to the CRO industry. It provides an overview of leading supergeneric organizations, their technologies, product development strategies, and partnering activities and analyzes market trends and the future outlook for the growth of supergeneric organizations.

“Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure”. The report provides a comprehensive overview of the healthcare expenditure, healthcare regulatory system, and pricing and reimbursement process with key data, information and analysis of pricing and reimbursement decisions, across 19 countries. The report closely scrutinizes the major changes in generic drugs-related pricing and reimbursement in the 19 countries over recent years and whose impact will be felt in the near future. It also describes the efforts taken by the governing bodies in shaping the pricing and reimbursement policies of generic drugs.

Reportreserve announces the inclusion of its new report in semi conductor industray